These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9508160)

  • 21. HIV/AIDS. Report of novel treatment aimed at latent HIV raises the 'c word'.
    Cohen J
    Science; 2005 Aug; 309(5737):999-1000. PubMed ID: 16099956
    [No Abstract]   [Full Text] [Related]  

  • 22. Toward HIV eradication or remission: the tasks ahead.
    Ho DD
    Science; 1998 Jun; 280(5371):1866-7. PubMed ID: 9669944
    [No Abstract]   [Full Text] [Related]  

  • 23. Low-level HIV-1 replication and the dynamics of the resting CD4+ T cell reservoir for HIV-1 in the setting of HAART.
    Sedaghat AR; Siliciano RF; Wilke CO
    BMC Infect Dis; 2008 Jan; 8():2. PubMed ID: 18171475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What can we do to reduce the viral reservoir in HIV-1-infected individuals?
    Pohlmeyer CW; Walker-Sperling VE; Blankson JN
    Future Microbiol; 2016 Jul; 11():839-42. PubMed ID: 27416850
    [No Abstract]   [Full Text] [Related]  

  • 25. A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children.
    Persaud D; Pierson T; Ruff C; Finzi D; Chadwick KR; Margolick JB; Ruff A; Hutton N; Ray S; Siliciano RF
    J Clin Invest; 2000 Apr; 105(7):995-1003. PubMed ID: 10749578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV infection: how effective is drug combination treatment?
    Grossman Z; Feinberg M; Kuznetsov V; Dimitrov D; Paul W
    Immunol Today; 1998 Nov; 19(11):528-32. PubMed ID: 9818549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV preferentially infects HIV-specific CD4+ T cells.
    Douek DC; Brenchley JM; Betts MR; Ambrozak DR; Hill BJ; Okamoto Y; Casazza JP; Kuruppu J; Kunstman K; Wolinsky S; Grossman Z; Dybul M; Oxenius A; Price DA; Connors M; Koup RA
    Nature; 2002 May; 417(6884):95-8. PubMed ID: 11986671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measuring HIV Persistence on Antiretroviral Therapy.
    Horsburgh BA; Palmer S
    Adv Exp Med Biol; 2018; 1075():265-284. PubMed ID: 30030797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measuring the Frequency of Latent HIV-1 in Resting CD4⁺ T Cells Using a Limiting Dilution Coculture Assay.
    Laird GM; Rosenbloom DI; Lai J; Siliciano RF; Siliciano JD
    Methods Mol Biol; 2016; 1354():239-53. PubMed ID: 26714716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure.
    Ruff CT; Ray SC; Kwon P; Zinn R; Pendleton A; Hutton N; Ashworth R; Gange S; Quinn TC; Siliciano RF; Persaud D
    J Virol; 2002 Sep; 76(18):9481-92. PubMed ID: 12186930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can HIV be eradicated?
    Pantaleo G; Perrin L
    AIDS; 1998; 12 Suppl A():S175-80. PubMed ID: 9633000
    [No Abstract]   [Full Text] [Related]  

  • 32. Immune activation and the pathogenesis of HIV disease: implications for therapy.
    Fernandez S; Lim A; French M
    J HIV Ther; 2009 Nov; 14(3):52-6. PubMed ID: 20218239
    [No Abstract]   [Full Text] [Related]  

  • 33. The emerging race to cure HIV infections.
    Cohen J
    Science; 2011 May; 332(6031):784-5, 787-9. PubMed ID: 21566173
    [No Abstract]   [Full Text] [Related]  

  • 34. Peering into the HIV reservoir.
    García M; Buzón MJ; Benito JM; Rallón N
    Rev Med Virol; 2018 Jul; 28(4):e1981. PubMed ID: 29744964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection.
    Tsai P; Wu G; Baker CE; Thayer WO; Spagnuolo RA; Sanchez R; Barrett S; Howell B; Margolis D; Hazuda DJ; Archin NM; Garcia JV
    Retrovirology; 2016 May; 13(1):36. PubMed ID: 27206407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Viral reservoirs, a challenging theme in HIV research].
    Avettand-Fènoël V
    Virologie (Montrouge); 2019 Aug; 23(4):193-194. PubMed ID: 31414657
    [No Abstract]   [Full Text] [Related]  

  • 37. Progress on prevention and cure.
    Jefferys R
    IAVI Rep; 2014; 18(1):4-11. PubMed ID: 24933924
    [No Abstract]   [Full Text] [Related]  

  • 38. Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4(+) T Cells from Aviremic Patients.
    Spivak AM; Bosque A; Balch AH; Smyth D; Martins L; Planelles V
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5984-91. PubMed ID: 26169416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.
    Chun TW; Stuyver L; Mizell SB; Ehler LA; Mican JA; Baseler M; Lloyd AL; Nowak MA; Fauci AS
    Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13193-7. PubMed ID: 9371822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can HIV infection be eradicated through use of potent antiviral agents?
    Josefsson L; Dahl V; Palmer S
    Curr Opin Infect Dis; 2010 Dec; 23(6):628-32. PubMed ID: 20847693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.